Fundraising Fox
Century Therapeutics, Inc.
NASDAQ: IPSCUnicorn · $1.1BPhiladelphia, US · Founded 2019 · 4 known investors
Find your way into Century Therapeutics, Inc.
Sign up to see every warm intro you have to Century Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Century Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Century Therapeutics develops allogeneic, iPSC-derived cell therapies using gene editing and protein engineering for autoimmune diseases including type 1 diabetes and cancer. The company aims to make cell therapies more effective, tolerable, accessible and affordable than existing treatments.
Founders & leadership
Board
Investors · 4
How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements▶$160MofferedMar 2021 · 22 investors · Other Health CareRule 506(b)
- Toshikazu BanDirector
- Carlo RizzutoDirector
- Joseph JimenezDirector
- Osvaldo Flores, Ph.D.Executive Officer, Director
- Douglas CarrExecutive Officer
- Eli CasdinDirector
- Cynthia ButittaDirector
- Juergen EckhardtDirector
- Offering amount
- $160M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Century Therapeutics, Inc. do?
- Century Therapeutics develops allogeneic, iPSC-derived cell therapies using gene editing and protein engineering for autoimmune diseases including type 1 diabetes and cancer. The company aims to make cell therapies more effective, tolerable, accessible and affordable than existing treatments.
- Who are Century Therapeutics, Inc.'s investors?
- Century Therapeutics, Inc.'s investors include LifeSci Venture Partners, RA Capital, Casdin Capital, Versant Ventures.
- Where is Century Therapeutics, Inc. headquartered?
- Century Therapeutics, Inc. is headquartered in Philadelphia, US.